Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Quick Stats
May 18, 202647.8
AI Score
HOLD0.48
Volume Ratio
May 12, 2026
Next Earnings
10
+ve Days (30d)
20
-ve Days (30d)
COGT Stock Summary
Last updated May 18, 2026
COGT is currently trading at $31.53, positioned above its 200-day moving average of $28.74, indicating a long-term uptrend. The stock has a 52-week range of $4.55 to $43.73.
Technical Analysis: The 50-day moving average stands at $35.72, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 27.35, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.174, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates COGT at 47.8/100 with a HOLD recommendation.
COGT (Cogent Biosciences, Inc. Common Stock) Indicators
Last updated May 18, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 27.35 |
| CMF (20) | -0.174 |
| ROC (10) | -13.64 |
| ADX (14) | 18.531 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.897 |
| AROONOSC (14) | -57.143 |
| WILLAMS %R (14) | -98.974 |
| MFI (14) | 46.897 |
COGT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
COGT Price vs Max Options Open Interest
COGT Max Change In Options Open Interest
COGT Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
COGT Daily Out of Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
COGT Daily In the Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
COGT Most Active Options by Volume(near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Cogent Biosciences, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
COGT Moving Averages Analysis
Cogent Biosciences, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 18, 2026
COGT (Cogent Biosciences, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated May 18, 2026
| Days | MA |
|---|---|
| 10 | 34.39 |
| 20 | 35.4 |
| 30 | 35.8 |
| 50 | 35.72 |
| 100 | 36.62 |
| 200 | 28.74 |
COGT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 5.8 billion |
| Earnings/Share ($) | -2.17 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.259 |
| EPS Estimate Next Year ($) | -0.9403 |
| WallStreet Target Price ($) | 54.25 |
| Most Recent Quarter |